StopDown
Cent logo
Launch · 6 March 2026CentPreventive health intelligence platformcentralbank.bank.in ↗

Cent launches with seed funding for early disease detection

By · Editor ·

seedBengaluruFounded 2025
  • Cent is a direct-to-consumer platform that uses imaging, biomarkers and AI to detect life-threatening diseases before symptoms appear
  • It raised undisclosed seed funding from OneFlow Holdings and South Park Commons, and has completed over 1,500 scans since Q1 FY26
  • India sees 1.5 million new cancer cases yearly, with 70% diagnosed late; Cent's Early Detection Index is 83% versus 15-20% for annual check-ups

What happened

  • Cent launched as a preventive health intelligence company for early detection of life-threatening diseases before symptoms appear.
  • It raised an undisclosed seed funding from OneFlow Holdings (Shashank's family office) and South Park Commons.
  • The platform combines advanced imaging, 120+ biomarkers, and AI-powered synthesis to detect cancer, cardiac, neurological, and metabolic risk in asymptomatic people.
  • Cent operates upstream of traditional physician-led diagnostic pathways, not as a diagnostic chain or wellness service.
  • It has been operational since Q1 FY26 and completed over 1,500 scans.
  • 26% of scans revealed clinically meaningful findings; 3-4% identified critical conditions needing immediate attention.
  • The Early Detection Index (EDI) stands at 83%, compared to 15-20% for conventional annual health check-ups.

Why it matters

  • India records over 1.5 million new cancer cases annually; about 70% are diagnosed at Stage III or IV, with five-year survival rates below 30% for most cancers.
  • India accounts for over one-fifth of global cardiovascular deaths; average first heart attack at age 53, a decade earlier than in Western populations.
  • Founder Shashank ND lost three family/close circle members to stage 4 cancer in 2024, motivating the launch.
  • Recent oncology funding deals include Oncare (Rs 27 crore), 4baseCare (Rs 90 crore), Everhope Oncology ($10M seed), and MOC Cancer Care & Research Centre ($18M).

The business

  • Cent is a direct-to-consumer platform combining advanced imaging, 120+ biomarkers, and AI-powered synthesis.
  • It detects cancer, cardiac, neurological, and metabolic risk in asymptomatic people.
  • Cent operates upstream of traditional physician-led diagnostic pathways, not as a diagnostic chain or wellness service.
  • Headquarters: Bengaluru.
  • Operational since Q1 FY26; completed over 1,500 scans.
  • 26% of scans revealed clinically meaningful findings; 3-4% identified critical conditions needing immediate attention.
  • Early Detection Index (EDI) at 83%, compared to 15-20% for conventional annual health check-ups.

The founders

Shashank ND

Founder and Chair
  • Founder and CEO of Practo.
  • Also founder and chair of Cent.
  • Lost three family/close circle members to stage 4 cancer in 2024, motivating the launch.

Arpit Garg

Co-founder and Chief AI and Research Officer
  • Ex-Lenskart.
  • Chief AI and research officer at Cent.

Anshul Khandelwal

Co-founder
  • Ex-Ola Electric.

Who put in money

In numbers

1500+Scans completed · FY26
26%Scans with clinically meaningful findings · FY26
3-4%Scans identifying critical conditions · FY26
83%Early Detection Index (EDI) · FY26
15-20%EDI for conventional annual check-ups
50000Target scans this year · 2026
10000000Long-term scan target · 2035
1000000Lives saved target · 2035

What happens next

  • On track to complete 50,000 scans this year.
  • First dedicated centres rolling out from April 2026 across Mumbai, Delhi, Bengaluru, then Pune and Hyderabad.
  • Long-term ambition: enable 10 million scans and contribute to one million lives saved by 2035.

Up against

ErlySignOncareOneCell Diagnostics4baseCareEverhope OncologyMOC Cancer Care & Research Centre

Words to know

biomarkers
Biological molecules in blood or other body fluids that indicate normal or abnormal processes, or a condition or disease.
asymptomatic
Showing no symptoms of a disease.
Early Detection Index (EDI)
A metric measuring the platform's ability to detect diseases early, compared to conventional methods.
seed funding
Early-stage investment to help a startup develop its product and initial operations.

The numbers around it

Cent has 2 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
27 October 2026Series A$15MBlume Ventures
31 March 2026seed$5 MnOneFlow Holdings

Healthcare & Life Sciences in March 2026: 16 rounds with a disclosed amount, $134 million in all; the biggest was Cult.fit (₹440 Cr ($47.2 Mn)). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
  • D2C: A D2C (direct-to-consumer) brand makes its own products and sells them straight to buyers, mostly online, with no distributor or shopkeeper between. It owns the customer and the data but pays to find every buyer. Survival depends on repeat purchases beating customer acquisition cost, and on contribution margin after delivery and returns.
  • Financial year: An Indian financial year runs from 1 April to 31 March, and it is named after the year it ends. FY26 means April 2025 to March 2026. Startup results for a year arrive months after it closes, so a November 2026 story may still be about FY25.

Everything on Cent → · All startup news on 6 March 2026 →

Is this Cent? Get your “Featured on StopDown” badge →